Celldex Therapeutics SVPs Engage In Heavy Transactions

Then on Jan. 2, 2026, Martin Samuel Bates, SVP and CFO, also acquired shares by exercising an option. He acquired 4,817 shares at a price of $10.38, worth $50,000. It’s unclear why both Ronald and Bates waited years to exercise their options, even though they reached their strike prices years earlier.Jimenez wasn’t the only SVP conducting insider transactions near the beginning of 2026. On Dec. 15, 2025, SVP & CBO Pepin Ronald acquired 19,333 shares by exercising two previously granted stock options. One op ...